Results 231 to 240 of about 178,510 (340)
Understanding Atopic Dermatitis: Pathophysiology and Management Strategies. [PDF]
Chai H, Siu WS, Ma H, Li Y.
europepmc +1 more source
ABSTRACT Atopic dermatitis (AD) involves chronic eczema resulting from barrier dysfunction. Fine bubble (FB) technology generates microbubbles (< 100 μm) and ultrafine bubbles (< 1 μm) for surfactant‐sparing cleansing. We assessed the short‐term safety of an FB shower in AD.
Hiroshi Kato +9 more
wiley +1 more source
Modulatory role of vitamin D in atopic dermatitis and allergic rhinitis. [PDF]
Devulapalli CS.
europepmc +1 more source
ABSTRACT Tralokinumab, an anti‐IL‐13 antibody, is effective for atopic dermatitis (AD); however, its long‐term (> 1 year) effectiveness specific to each anatomical site is unknown in real‐world settings. To evaluate 72‐week effectiveness of tralokinumab on different anatomical sites in AD, we studied 208 patients with moderate‐to‐severe AD treated with
Mizuki Shiba +6 more
wiley +1 more source
Defining "Flares" in Atopic Dermatitis: A Narrative Review. [PDF]
Merola JF +4 more
europepmc +1 more source
Mycosis Fungoides Is a Proliferation of Multiple Mutational Subclones
ABSTRACT Mycosis fungoides (MF) is a unique type of lymphoma with an excellent prognosis presenting with a wide variety of clinical and histological findings. Recent sophisticated research techniques have revealed that very slow changes in the clinical and histological pictures of one patient over time are due to intratumoral heterogeneity.
Ryoma Honda +2 more
wiley +1 more source

